120 related articles for article (PubMed ID: 402665)
1. Is tolerance to delta-9-THC cellular or metabolic? The subcellular distribution of delta-9-tetrahydrocannabinol and its metabolites in brains of tolerant and non-tolerant rats.
Magour S; Coper H; Fähndrich C
Psychopharmacology (Berl); 1977 Jan; 51(2):141-5. PubMed ID: 402665
[TBL] [Abstract][Full Text] [Related]
2. An attempt to correlate the development of tolerance to delta-9-tetrahydrocannabinol and d-amphetamine with their subcellular distribution in rat brain.
Magour S; Coper H; Fähndrich C
Pol J Pharmacol Pharm; 1976; 28(6):589-92. PubMed ID: 1012982
[TBL] [Abstract][Full Text] [Related]
3. Chronic cannabinoid administration alters cannabinoid receptor binding in rat brain: a quantitative autoradiographic study.
Oviedo A; Glowa J; Herkenham M
Brain Res; 1993 Jul; 616(1-2):293-302. PubMed ID: 8395305
[TBL] [Abstract][Full Text] [Related]
4. The effects of morphine and delta-9-tetrahydrocannabinol on motor activity in rats.
Tulunay FC; Ayhan IH; Sparber SB
Psychopharmacology (Berl); 1982; 78(4):358-60. PubMed ID: 6296906
[TBL] [Abstract][Full Text] [Related]
5. Brain levels of delta1-tetrahydrocannabinol and its metabolites in mice tolerant to the hypothermic effect of delta1-tetrahydrocannabinol.
Lawrence DK; Pertwee RG
Br J Pharmacol; 1973 Oct; 49(2):373-5. PubMed ID: 4793443
[TBL] [Abstract][Full Text] [Related]
6. Sex differences in Δ(9)-tetrahydrocannabinol metabolism and in vivo pharmacology following acute and repeated dosing in adolescent rats.
Wiley JL; Burston JJ
Neurosci Lett; 2014 Jul; 576():51-5. PubMed ID: 24909619
[TBL] [Abstract][Full Text] [Related]
7. Ethanol and delta-9-tetrahydrocannabinol: mechanism for cross-tolerance in mice.
Sprague GL; Craigmill AL
Pharmacol Biochem Behav; 1976 Oct; 5(4):409-15. PubMed ID: 1005489
[TBL] [Abstract][Full Text] [Related]
8. The effect of (-)-trans-delta 9-tetrahydrocannabinol on regional brain levels and subcellular distribution of monoamines in the rat.
Taylor DA; Fennessy MR
Clin Exp Pharmacol Physiol; 1979; 6(5):541-8. PubMed ID: 498594
[TBL] [Abstract][Full Text] [Related]
9. Cross-tolerance to the hypothermic effect of delta 8-tetrahydrocannabinol 11-hydroxy-delta 8-tetrahydrocannabinol and chlorpromazine in the mouse.
Yamamoto I; Watanabe K; Narimatsu S; Hamajima K; Yoshimura H
Eur J Pharmacol; 1985 May; 111(2):159-66. PubMed ID: 2990949
[TBL] [Abstract][Full Text] [Related]
10. Cross-tolerance between delta9-tetrahydrocannabinol and ethanol: the role of drug disposition.
Siemens AJ; Doyle OL
Pharmacol Biochem Behav; 1979 Jan; 10(1):49-55. PubMed ID: 441094
[TBL] [Abstract][Full Text] [Related]
11. Time course for the induction and maintenance of tolerance to Delta(9)-tetrahydrocannabinol in mice.
Bass CE; Martin BR
Drug Alcohol Depend; 2000 Aug; 60(2):113-9. PubMed ID: 10940538
[TBL] [Abstract][Full Text] [Related]
12. Effects of chronic administration of delta 9-tetrahydrocannabinol on the cardiovascular system, and pressor and behavioral responses to brain stimulation in freely moving rats.
Kawasaki H; Watanabe S; Ueki S
Eur J Pharmacol; 1980 Jul; 65(1):63-9. PubMed ID: 6249621
[TBL] [Abstract][Full Text] [Related]
13. Development of tolerance and cross-tolerance to the cataleptogenic effects of delta 8-tetrahydrocannabinol and 11-hydroxy-delta 8-tetrahydrocannabinol in mice.
Watanabe K; Yamamoto I; Yoshimura H
Eur J Pharmacol; 1983 Oct; 94(3-4):349-51. PubMed ID: 6317407
[TBL] [Abstract][Full Text] [Related]
14. 3H-delta 9-Tetrahydrocannabinol, 3H-cannabinol and 3H-cannabidiol: penetration and regional distribution in rat brain.
Alozie SO; Martin BR; Harris LS; Dewey WL
Pharmacol Biochem Behav; 1980 Feb; 12(2):217-21. PubMed ID: 6246544
[TBL] [Abstract][Full Text] [Related]
15. Penetration of delta-9-tetrahydrocannabinol and 11-OH-delta-9-tetrahydrocannabinol through the blood-brain barrier.
Schou J; Prockop LD; Dahlstrom G; Rohde C
Acta Pharmacol Toxicol (Copenh); 1977 Jul; 41(1):33-8. PubMed ID: 578377
[TBL] [Abstract][Full Text] [Related]
16. Behavioral and molecular changes elicited by acute administration of SR141716 to Delta9-tetrahydrocannabinol-tolerant rats: an experimental model of cannabinoid abstinence.
González S; Fernández-Ruiz J; Di Marzo V; Hernández M; Arévalo C; Nicanor C; Cascio MG; Ambrosio E; Ramos JA
Drug Alcohol Depend; 2004 May; 74(2):159-70. PubMed ID: 15099659
[TBL] [Abstract][Full Text] [Related]
17. Relationship between the subcellular distribution of delta-9-tetrahydrocannabinol and its metabolites in rat brain and the duration of the effect on motor activity.
Magour S; Coper H; Fähndrich C; Hill R
Life Sci; 1976 Mar; 18(6):575-84. PubMed ID: 1263740
[No Abstract] [Full Text] [Related]
18. Effect of delta 9-tetrahydrocannabinol on the morphine-induced hyperactivity of mice.
Ulkü E; Ayhan IH; Tulunay FC; Uran B; Kaymakçalan S
Psychopharmacology (Berl); 1980; 69(2):201-5. PubMed ID: 6256790
[TBL] [Abstract][Full Text] [Related]
19. Plasma and brain levels of delta 6-THC and seven monooxygenated metabolites correlated to the cataleptic effect in the mouse.
Ohlsson A; Widman M; Carlsson S; Ryman T; Strid C
Acta Pharmacol Toxicol (Copenh); 1980 Oct; 47(4):308-17. PubMed ID: 6258385
[TBL] [Abstract][Full Text] [Related]
20. Repeated administration of phytocannabinoid Δ(9)-THC or synthetic cannabinoids JWH-018 and JWH-073 induces tolerance to hypothermia but not locomotor suppression in mice, and reduces CB1 receptor expression and function in a brain region-specific manner.
Tai S; Hyatt WS; Gu C; Franks LN; Vasiljevik T; Brents LK; Prather PL; Fantegrossi WE
Pharmacol Res; 2015 Dec; 102():22-32. PubMed ID: 26361728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
